浏览全部资源
扫码关注微信
1.复旦大学附属中山医院药剂科,上海 200032
2.国家卫生健康委医院管理研究所药事管理研究部,北京 100044
3.上海市老年医学中心药剂科,上海 201104
Published:15 October 2024,
Received:07 March 2024,
Revised:18 August 2024,
移动端阅览
赵婧,孙路路,吕红梅等.我国医疗机构PIVAS医嘱审核情况调研分析 Δ[J].中国药房,2024,35(19):2340-2344.
ZHAO Jing,SUN Lulu,LYU Hongmei,et al.Investigation and analysis of the medical prescription approval in PIVAS in China[J].ZHONGGUO YAOFANG,2024,35(19):2340-2344.
赵婧,孙路路,吕红梅等.我国医疗机构PIVAS医嘱审核情况调研分析 Δ[J].中国药房,2024,35(19):2340-2344. DOI: 10.6039/j.issn.1001-0408.2024.19.04.
ZHAO Jing,SUN Lulu,LYU Hongmei,et al.Investigation and analysis of the medical prescription approval in PIVAS in China[J].ZHONGGUO YAOFANG,2024,35(19):2340-2344. DOI: 10.6039/j.issn.1001-0408.2024.19.04.
目的
2
了解全国医疗机构静脉用药调配中心(PIVAS)医嘱审核现状,进一步提升PIVAS医嘱管理水平,减少与杜绝静脉给药错误的发生。
方法
2
通过问卷调研法,针对全国医疗机构PIVAS医嘱审核的问题和现状,由调研组中的各省(自治区、直辖市)专家负责组织本省份内相关医疗机构的PIVAS负责人填写医嘱审核和不适宜医嘱干预情况的问卷,并对结果进行统计分析。
结果
2
共收到关于PIVAS医嘱审核的有效问卷751份。我国PIVAS医嘱审核主要以人工与计算机相结合的方式进行。PIVAS每日医嘱审核条数的中位数为700.00~771.00条;每日新增医嘱审核条数的中位数为209.68~215.00条;平均医嘱审核率为85.50%~92.44%;不适宜医嘱平均占比为1.82%~1.89%;不适宜医嘱平均干预率为74.90%~79.41%,平均干预成功率为79.62%~87.28%;退药率为2.92%~3.08%。
结论
2
我国大部分医疗机构PIVAS的医嘱审核采用审方软件辅助,个别PIVAS存在医嘱不审核、不适宜医嘱不干预等情况,医嘱审核的标准及流程有待完善。建议强调药师审方责任制,规范化使用审方软件,逐步扩大医嘱审核范围,并采用多部门协作方式,从而提高不适宜医嘱的干预成功率、降低PIVAS退药率。
OBJECTIVE
2
To know about the current status of medical order auditing in pharmacy intravenous admixture service (PIVAS) of medical institutions nationwide, further improve the management of medical orders in PIVAS, and reduce and eliminate the occurrence of intravenous medication administration errors.
METHODS
2
Through the questionnaire survey method, to address the problems and current situation of PIVAS medical order auditing in medical institutions nationwide, experts from each province (autonomous region, municipality directly under the central government) in the research group were responsible for organizing the PIVAS directors of relevant medical institutions in their provinces to fill in the questionnaires on medical order audit and inappropriate medical order interventions, and conduct a statistical analysis of the results.
RESULTS
2
A total of valid 751 responses were received to the PIVAS questionnaire on the review of medical prescriptions. Our PIVAS medical order audit is mainly carried out by a combination of manual and computer. The median number of medical orders were audited by PIVAS per day were 700.00-771.00; the median number of new medical orders were audited by PIVAS per day were 209.68-215.00; medical order auditing rates were 85.50%-92.44% averagely; the inappropriate doctor’s orders accounted for 1.82%-1.89% averagely; the intervention rates of inappropriate medical orders ranged 74.90%-79.41%, the success rates of intervention were 79.62%-87.28% averagely; the medication refund rates were 2.92%-3.08%.
CONCLUSIONS
2
Most of the PIVAS in China’s healthcare institutions use medical order review software to assist in the review of medical orders, and there are cases of individual PIVAS in which medical orders are not reviewed comprehensively and inappropriate orders are not intervened in, and the standards and processes of medical prescription review need to be improved. It is recommended to emphasize the pharmacist’s responsibility system, standardize the use of prescription review software; gradually expand the scope of medical order review, and adopt a multi-departmental collaborative approach so as to increase the success rate of intervention for inappropriate prescriptions and reduce the rate of PIVAS withdrawals.
静脉用药调配中心医嘱审核审方软件
medical order auditingprescription review software
周利军,沈绍清,吴斯宇,等. 某院实施静配医嘱审核服务的效果及成因分析[J]. 中国医药导报,2018,15(3):176-180.
ZHOU L J,SHEN S Q,WU S Y,et al. Effect evaluation and causal analysis of medication orders of PIVAS examination in a hospital[J]. China Med Her,2018,15(3):176-180.
刘珠英,黄际薇,刘杰. 我院PIVAS规范医嘱审核工作实践[J]. 中国药房,2017,28(31):4462-4464.
LIU Z Y,HUANG J W,LIU J. Practice of standardization work of medical orders auditing in PIVAS of our hospital[J]. China Pharm,2017,28(31):4462-4464.
王亚峰,贺葵邦,白菊,等. 基于“药师+智慧软件”的PIVAS全医嘱审核药学服务模式[J]. 医药导报,2019,38(3):403-406.
WANG Y F,HE K B,BAI J,et al. Establishment of pharmaceutical care mode of PIVAS prescription review based on pharmacist and software[J]. Her Med,2019,38(3):403-406.
魏小丽,于丹. 静脉用药调配中心使用前后不合理医嘱及药物干预比较研究[J]. 实用临床医药杂志,2022,26(7):36-38.
WEI X L,YU D. Comparison in unreasonable medical orders and drug intervention before and after application of pharmacy intravenous admixture services[J]. J Clin Med Pract,2022,26(7):36-38.
刘国强,杨警囡. 我国静脉用药调配中心不合理医嘱现状的文献计量学分析[J]. 中国药业,2022,31(5):120-123.
LIU G Q,YANG J N. Current situation of unreasonable medical orders in PIVAS in China based on bibliometrics[J]. China Pharm,2022,31(5):120-123.
孟祥君. 静脉药物配置中心审核的不合理医嘱原因及干预效果回顾性分析[J]. 中国病案,2023,24(4):109-112.
MENG X J. Retrospective analysis of reasons and intervention effects of unreasonable medical orders audited by intravenous drug allocation center[J]. Chin Med Rec,2023,24(4):109-112.
肖莉娜,张建中,王春晖. 我院静脉用药不合理医嘱的监测、调查与分析[J]. 上海医药,2016,37(21):57-62.
XIAO L N,ZHANG J Z,WANG C H. Monitoring of irrational doctor’s advice on intravenous medication at PIVAS[J]. Shanghai Med Pharm J,2016,37(21):57-62.
宋梦如,刘姗姗,吴杲,等. 智能审方系统+新型药学服务在改进静脉药物集中配置中心工作模式中的作用初探[J]. 中国医院用药评价与分析,2023,23(9):1143-1148,1152.
SONG M R,LIU S S,WU G,et al. Role of intelligent prescription review system + new type of pharmaceutical service in improving working mode of pharmacy intravenous admixture services[J]. Eval Anal Drug Use Hosp China,2023,23(9):1143-1148,1152.
周月,周宇,商永光. 静脉用药调配中心智能化医嘱审核系统的应用与评价[J]. 临床药物治疗杂志,2024,22(1):61-64.
ZHOU Y,ZHOU Y,SHANG Y G. Application and eva- luation of intelligent medical order review system in pharmacy intravenous admixture services[J]. Clin Med J,2024,22(1):61-64.
毛擎,吴淑华,李培芳,等. 静脉配置中心医嘱审核相关功能的持续改进与完善[J]. 实用医院临床杂志,2019,16(1):87-89.
MAO Q,WU S H,LI P F,et al. Continuous improvement in related functions of doctor’s advice review in pharmacy intravenous admixture services[J]. Pract J Clin Med,2019,16(1):87-89.
阿米妮古丽·奥布力喀斯木,哈力旦·阿布力米提. 合理用药系统在静脉用药调配中心的应用[J]. 中国保健营养,2020,30(32):274.
Aminiguli Aobulikasimu,Halidan Abulimiti.Application of rational drug use system in intravenous drug use allocation center[J]. China Health Care Nutr,2020,30(32):274.
郑学海,邓艾平. 多环节质量控制在降低静配中心退药率的应用实践[J]. 中国医院药学杂志,2017,37(19):1989-1992.
ZHENG X H,DENG A P. Application of multi-section quality control in reducing the rate of drug repercussion[J]. Chin J Hosp Pharm,2017,37(19):1989-1992.
鹿新丽. 采用多环节质量控制在降低静配中心退药率中的应用效果[J]. 中国保健营养,2021,31(13):12-13.
LU X L. The application effect of multi-link quality control in reducing the drug withdrawal rate of static distribution center[J]. China Health Care Nutr,2021,31(13):12-13.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution